Patents/Assignees

Silver Creek Pharmaceuticals, Inc.

4 patents in portfolio

US12122819utility2024
Method of Treating Skin Tissue Damage by Topically Administering a Bi-specific Protein Comprising a Human Insulin-like Growth Factor Variant and a Human Annexin A5 Variant
0 cites
US11879002utility2024
Bi-specific Therapeutic Proteins, in Vivo Methods of Use Thereof and Encoding Nucleic Acids Thereof
0 cites
US11814443utility2023
Bi-specific Fusion Proteins
0 cites
US11673970utility2023
Bi-specific Fusion Proteins
0 cites